Daniel K. Storino

Mar 19, 2024 | mondaq.com | Gail F. Levine |Thomas V. Panoff |Daniel K. Storino |Scott Perlman

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. The public comment period is a good opportunity for private equity firms to weigh in.

Mar 11, 2024 | today.westlaw.com | Rachel J. Lamorte |Thomas V. Panoff |Daniel K. Storino |Jeremy Silas

(May 01, 2024) - Mayer Brown LLP attorneys Rachel Lamorte, Thomas Panoff, Daniel Storino and Jeremy Silas discuss an announcement by three federal regulators that they are looking into private equity's "increasing control over health care."•Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. •The public comment period is a good opportunity for private equity firms to weigh in.